New Stock News | Anno Uda Submits for the Third Time to Hong Kong Stock Exchange

06:24 16/04/2026

According to the disclosure of the Hong Kong Stock Exchange on April 15, Annoroad Gene Technology (Beijing) Co., Ltd. (referred to as Annoroad) submitted its third application for listing on the main board of the Hong Kong Stock Exchange, with CICC and Guotai Junan International as its joint sponsors.

According to the disclosure of the Hong Kong Stock Exchange on April 15, Annoroad Gene Technology (Beijing) Co., Ltd. (referred to as "Annoroad") submitted its third listing application to the main board of the Hong Kong Stock Exchange, with CIMB International and Guotai Haitong as its joint sponsors. According to the prospectus, the company's NIPT test kit obtained three types of medical device certificates in 2017, making it one of the few companies in China to achieve this milestone. The company has further developed the CNV-seq test kit and obtained three types of medical device certificates in 2024. The company is focused on molecular diagnostics-based IVD medical devices and omics life science research services.

China Securities Co., Ltd.: Continued high prosperity in the global optical communication industry, five years of growth expected.

China Securities Co., Ltd.: Siasun Robot&Automation sector is gradually entering the consolidation range, it is recommended to focus on high-quality segments at the bottom.

Sinolink: Focus on Three Core Devices as Optic Modules Evolve towards High-Speed Rates and CPOadvancements.

China Securities Co., Ltd.: Continued high prosperity in the global optical communication industry, five years of growth expected.

China Securities Co., Ltd.: Siasun Robot&Automation sector is gradually entering the consolidation range, it is recommended to focus on high-quality segments at the bottom.

Sinolink: Focus on Three Core Devices as Optic Modules Evolve towards High-Speed Rates and CPOadvancements.